BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25603286)

  • 21. RSwitch: A Novel Bioinformatics Database on Riboswitches as Antibacterial Drug Targets.
    Penchovsky R; Pavlova N; Kaloudas D
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):804-808. PubMed ID: 32248122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The adenine riboswitch: a new gene regulation mechanism].
    Lemay JF; Lafontaine DA
    Med Sci (Paris); 2006 Dec; 22(12):1053-9. PubMed ID: 17156726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a 1,4-disubstituted 1,2,3-triazole binding to T box antiterminator RNA.
    Zhou S; Means JA; Acquaah-Harrison G; Bergmeier SC; Hines JV
    Bioorg Med Chem; 2012 Feb; 20(3):1298-302. PubMed ID: 22230198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Riboswitches as antibacterial drug targets.
    Blount KF; Breaker RR
    Nat Biotechnol; 2006 Dec; 24(12):1558-64. PubMed ID: 17160062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unconventional screening approaches for antibiotic discovery.
    Farha MA; Brown ED
    Ann N Y Acad Sci; 2015 Sep; 1354():54-66. PubMed ID: 26100135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence assays for monitoring RNA-ligand interactions and riboswitch-targeted drug discovery screening.
    Liu J; Zeng C; Zhou S; Means JA; Hines JV
    Methods Enzymol; 2015; 550():363-83. PubMed ID: 25605395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile.
    Yan LH; Le Roux A; Boyapelly K; Lamontagne AM; Archambault MA; Picard-Jean F; Lalonde-Seguin D; St-Pierre E; Najmanovich RJ; Fortier LC; Lafontaine D; Marsault É
    Eur J Med Chem; 2018 Jan; 143():755-768. PubMed ID: 29220796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of SBDD to the discovery of new antibacterial drugs.
    Finn J
    Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial histidine kinases as novel antibacterial drug targets.
    Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
    ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 32. Employing a ZTP Riboswitch to Detect Bacterial Folate Biosynthesis Inhibitors in a Small Molecule High-Throughput Screen.
    Perkins KR; Atilho RM; Moon MH; Breaker RR
    ACS Chem Biol; 2019 Dec; 14(12):2841-2850. PubMed ID: 31609568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel ligands for thiamine pyrophosphate (TPP) riboswitches.
    Cressina E; Chen L; Moulin M; Leeper FJ; Abell C; Smith AG
    Biochem Soc Trans; 2011 Apr; 39(2):652-7. PubMed ID: 21428956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for new antibiotics: a molecule-centered perspective.
    Walsh CT; Wencewicz TA
    J Antibiot (Tokyo); 2014 Jan; 67(1):7-22. PubMed ID: 23756684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system.
    Kirchner M; Schorpp K; Hadian K; Schneider S
    Sci Rep; 2017 Aug; 7(1):7732. PubMed ID: 28798404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic inactivation of bacteria: finding the effective targets.
    Almeida A; Faustino MA; Tomé JP
    Future Med Chem; 2015; 7(10):1221-4. PubMed ID: 26144260
    [No Abstract]   [Full Text] [Related]  

  • 38. Fragment-based screening identifies novel targets for inhibitors of conjugative transfer of antimicrobial resistance by plasmid pKM101.
    Casu B; Arya T; Bessette B; Baron C
    Sci Rep; 2017 Nov; 7(1):14907. PubMed ID: 29097752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integron attI1 sites, not riboswitches, associate with antibiotic resistance genes.
    Roth A; Breaker RR
    Cell; 2013 Jun; 153(7):1417-8. PubMed ID: 23791167
    [No Abstract]   [Full Text] [Related]  

  • 40. Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design.
    Tran B; Pichling P; Tenney L; Connelly CM; Moon MH; Ferré-D'Amaré AR; Schneekloth JS; Jones CP
    Cell Chem Biol; 2020 Oct; 27(10):1241-1249.e4. PubMed ID: 32795418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.